Mitochondrial Disorders 2
The Mitochondrial Disorders 2 session will be an overview of clinical mitochondrial phenotypes.
This educational activity is supported by an educational grant from Ultragenyx.
- Identify an mtDNA pathogenic variant that is commonly associated with Leigh Syndrome.
- Interpret the clinical significance of blood heteroplasmy for m.3243 A>G at older versus younger ages.
- Explain the different mechanisms accounting for phenotypic differences between males and females with PDHA1-related disease.
Austin Larson, MD
Children's Hospital Colorado
Austin Larson, MD, speaker for this session, is a site principle investigator for clinical trial for Travere, Stealth, Astellas and Astellas, and a consultant for Illumina.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance